Don’t fret if you’re having trouble finding the bird you need this year.
As cases of COVID-19 spike around the country, the CDC advises revelers to stay put.
Early data from clinical trials suggests that the immunization is promising, but we’ll still be waiting a while.
Moderna’s coronavirus vaccine candidate is 94.5 percent effective in early late-stage clinical trials.
The overall odds are still quite low.
Nearly 300,000 people have died in excess compared to years prior.
The technology can alter human, plant, and microbial DNA with relative ease and extreme precision.
Plus: what we know about what Trump is (and isn’t) taking.
Reebok’s vice president for apparel talks about how researchers perfected compression technology in a sports bra.
Here’s everything you need to know this week.
Like science, tech, and DIY projects?
Sign up to receive Popular Science's emails and get the highlights.